RxDoctor Payments DataLook up a doctor →

Joseph Smucker, MD

Orthopaedic Surgery of the Spine · Carmel, INNPI 1225029655

Payments from drug & device makers

$994,248in general payments, 2019–2025

Across 235 payments — averaging $4230.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$988K
  • Zimmer Biomet$6K
  • Nevro Corp.$90
  • Globus Medical$64
  • Spineart USA Inc$26
  • Carlsmed, Inc.$14
  • plus $12 from 1 others
$79,891in research payments, 2019–2025

Across 31 payments — averaging $2577.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$80K

What the payments were for

  • Consulting fees$3,5009%
  • Speaking & faculty fees$22,10057%
  • Travel & lodging$5,10813%
  • Food & beverage$2,0975%
  • Education$5,77715%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)213$988,266
Zimmer Biomet15$5,777
Nevro Corp.2$90
Globus Medical2$64
Spineart USA Inc1$26
Carlsmed, Inc.1$14
Biocomposites Inc1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$994,248 in reported general payments places this provider in the 90th percentile of 48 orthopaedic surgery of the spine providers in Indiana.

See all orthopaedic surgery of the spine providers in Indiana

Medicare billing

Part B allowed, 2024
$243,327
Medicare patients
292
Services billed
1,399

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin151$1,996
Pregabalin25$361

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →